HIV/AIDS Clinical Trials in Philadelphia

Showing 461-480 of 621 trials

Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV

NCT00130273

This study will determine whether a managed problem solving intervention can help patients with HIV better follow their anti-HIV drug regimen and can control HIV better than the standard of care.

HIV Infections

University of Pennsylvania180 participantsStarted Jul 2005

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520

The purpose of this study is to compare the effectiveness, safety, and tolerability of 3 anti-HIV combination treatments that do not use protease inhibitors (PIs). The current rule for starting treatment of HIV infection is to combine members from different classes of anti-HIV drugs, such as 2 nucleoside reverse transcriptase inhibitors (NRTIs) and either a PI or a nonnucleoside reverse transcriptase inhibitor (NNRTI). However, these combinations can be complicated and difficult to take, can cause a number of side effects, and may become ineffective. Combinations that are simpler, better tolerated, and more effective are needed. Because PIs can cause long-term side effects and because HIV can become resistant to many of them at the same time, anti-HIV combination treatments that do not use PIs are being tested.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)1,125 participants

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +57 more locations

Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

HIV/AIDS Trials in Other Cities

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Evaluation of Diagnostic HIV Ag/Ab Combo Assay

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Other Conditions in Philadelphia